HLA-DRB1*1101: a significant risk factor for sarcoidosis in blacks and whites. - Wikidata - awgldk - TriplyDB

HLA-DRB1*1101: a significant risk factor for sarcoidosis in blacks and whites.

HLA-DRB1*1101: a significant risk factor for sarcoidosis in blacks and whites.

http://www.wikidata.org/entity/Q33905995

about

The BTNL2 gene and sarcoidosis susceptibility in African Americans and Whites A concise review of pulmonary sarcoidosis Identification of HLA-DRPhebeta47 as the susceptibility marker of hypersensitivity to beryllium in individuals lacking the berylliosis-associated supratypic marker HLA-DPGlubeta69.Sarcoidosis Occurring After Solid Cancer: A Nonfortuitous Association: Report of 12 Cases and Review of the Literature Granuloma formation in pulmonary sarcoidosis Identifying Novel Biomarkers in Sarcoidosis Using Genome-Based Approaches Sarcoidosis and human leukocyte antigen class I and II genes: it takes two to tango?Association Between Occupational Exposures and Sarcoidosis: An Analysis From Death Certificates in the United States, 1988-1999 Gene expression profiling identifies MMP-12 and ADAMDEC1 as potential pathogenic mediators of pulmonary sarcoidosis.Potential etiologic agents in sarcoidosis.Mycobacterial ESAT-6 and katG are recognized by sarcoidosis CD4+ T cells when presented by the American sarcoidosis susceptibility allele, DRB1*1101.Genetic variants in mannose receptor gene (MRC1) confer susceptibility to increased risk of sarcoidosis.RNA-sequencing Identifies Novel Pathways in Sarcoidosis Monocytes.Different HLA-DRB1 allele distributions in distinct clinical subgroups of sarcoidosis patients.Performance of HLA allele prediction methods in African Americans for class II genes HLA-DRB1, -DQB1, and -DPB1.Genetic predisposition to respiratory diseases: infiltrative lung diseases.Sarcoidosis--scientific progress and clinical challenges.The association of PTPN22 rs2476601 polymorphism and CTLA-4 rs231775 polymorphism with LADA risks: a systematic review and meta-analysis Sarcoidosis is associated with a truncating splice site mutation in BTNL2.Genome-wide association study of African and European Americans implicates multiple shared and ethnic specific loci in sarcoidosis susceptibility Peripheral blood gene expression as a novel genomic biomarker in complicated sarcoidosis.Expression of receptor for advanced glycation end products in sarcoid granulomas.Human leukocyte antigen-A, -B, -C, -DRB1 allele and haplotype frequencies in Americans originating from southern Europe: contrasting patterns of population differentiation between Italian and Spanish Americans.Development of a sarcoidosis murine lung granuloma model using Mycobacterium superoxide dismutase A peptide.Analysis of BTNL2 genetic polymorphisms in British and Dutch patients with sarcoidosis.HLA class I and class II frequencies in patients with sarcoidosis from Croatia: role of HLA-B8, -DRB1*0301, and -DQB1*0201 haplotype in clinical variations of the disease.A genome-wide admixture scan for ancestry-linked genes predisposing to sarcoidosis in African-Americans.Fas promoter polymorphisms: genetic predisposition to sarcoidosis in African-Americans.Performance of LIFECODES HLA-DQB1 typing kit using Luminex platform in Koreans.Sarcoidosis HLA class II genotyping distinguishes differences of clinical phenotype across ethnic groups.Differential inflammatory microRNA and cytokine expression in pulmonary sarcoidosis.Sarcoidosis in the national veteran population: association of ocular inflammation and mortality Comparative Proteomic Analysis of Two Uveitis Models in Lewis Rats Gene-environment interactions in sarcoidosis: challenge and opportunity.Association of HLA-DRB1 with Sarcoidosis Susceptibility and Progression in African Americans.Granuloma genes in sarcoidosis: what is new?Genetics of Crohn disease, an archetypal inflammatory barrier disease.Identification of Immune-Relevant Factors Conferring Sarcoidosis Genetic Risk The association between osteopontin gene polymorphisms, osteopontin expression and sarcoidosis.HLA-DP genetic variation, proxies for early life immune modulation and childhood acute lymphoblastic leukemia risk.

P2860

Q24534029-DBB866F3-B066-4E21-904E-08C415108923 Q24609077-25E9BB8C-0D84-43B7-B7F5-85EF6A7AEB70 Q24811040-D615B53C-BE21-436F-AF25-621C3DB0668D Q26800215-43878A9E-2E43-44C2-ABA7-D4BFD74BB6D8 Q26863703-BE29AB56-0464-4C6F-8828-127A07F957CE Q28082850-21A0BC1F-9996-4E65-8309-67884D5D5A04 Q28248694-2C3C361A-1CD3-4D01-B58E-0AB38E3BE855 Q28386288-415575D7-6B61-4843-9D50-6AB0D43095EB Q30487702-D59D3F80-FA78-4022-9C1B-484A9781F8D5 Q33293512-7A83EA99-46CB-42AD-8DE9-CC54FCB2370E Q33651342-F018A6DC-E178-4534-A075-6C0D43288595 Q33732137-68BC4BDD-55BD-47B1-8C2C-D66445685189 Q33758739-774A641D-6C6C-47D4-83D9-083237FD83F9 Q33758860-226F7D02-4DC7-40C8-AACA-97E00CC12B54 Q33820408-171E4CDD-752A-498F-A241-C7ADF0009D14 Q34010166-6A101145-AACB-4F19-83E1-A8501C5C6605 Q34199947-4F1B8174-5972-4273-994C-016856EBCA64 Q34252769-72C14981-B0BA-4238-89EC-E53017EB6CF4 Q34398412-49A61E6B-E868-40FD-B8C7-2CB72ADE3D5A Q34405821-0183A54A-4F3B-434C-829E-AB45EEC41324 Q34416157-A850881B-9B6D-46DA-9D7A-D9B2132518C2 Q34591271-F493A2CC-55EB-48CF-A2DC-741ECC7FD675 Q34610698-A2771101-3197-4FA2-9C92-F226931025EC Q34626531-7F180F4C-2530-4398-A398-E1EF848A2044 Q34657366-76824E6B-7D4A-4303-97A0-2B174A5ADFA3 Q34674524-379C7948-FF62-42BB-926A-EA282CB9B8E1 Q34682697-E2807286-35BF-4CAA-AF48-29C0A4E7FD2A Q34702518-1BAB6547-737E-4CAC-9AAF-85CA6D14E8C8 Q34749594-B1D2C697-848E-4648-95C8-D3FCA6B5DDF6 Q35152804-42FE5031-25EE-47CC-80A2-66BBE159B2BE Q35176239-1A509F63-C06C-46D1-9199-E702AF396BC3 Q35554332-4E70BB2E-2EC2-4D46-92FF-FBC6B5895310 Q35889289-19950BCA-540D-4C9B-A90E-BECD77E6B8F4 Q35895044-D2F0509D-E863-45F0-A040-EEFDA0CF0C5E Q36049206-09E8A26E-521A-4484-926A-F7D034C027B2 Q36057780-7B60DE23-9061-4A20-8DC7-B5F8AF03F9EB Q36110574-F2C43072-96F9-4A8A-82F3-708FEE640E36 Q36128550-BC83F101-FE7B-43EA-9EDE-EA3B2B2951AA Q36295223-134B5750-286E-43C8-A0C8-B83E8665E186 Q36318142-A5E52DB0-7CD6-48CD-816D-B66FF2F71343

P2860

HLA-DRB1*1101: a significant risk factor for sarcoidosis in blacks and whites.

http://www.wikidata.org/entity/Q33905995

description

2003 nî lūn-bûn

@nan

2003 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

HLA-DRB1*1101: a significant risk factor for sarcoidosis in blacks and whites.

@ast

HLA-DRB1*1101: a significant risk factor for sarcoidosis in blacks and whites.

@en

type

label

HLA-DRB1*1101: a significant risk factor for sarcoidosis in blacks and whites.

@ast

HLA-DRB1*1101: a significant risk factor for sarcoidosis in blacks and whites.

@en

prefLabel

HLA-DRB1*1101: a significant risk factor for sarcoidosis in blacks and whites.

@ast

HLA-DRB1*1101: a significant risk factor for sarcoidosis in blacks and whites.

@en

P1433

Q33905995-20745BDF-7D68-406E-8CAF-0DA3199374A0

P1476

Q33905995-43A3B809-3501-49F9-AFD2-DBE036F07228

P2093

Q33905995-149C14EC-8D37-41C3-BE3E-9016E1EF5AD6

Q33905995-1C4E3834-3F30-4DF3-91F1-76B6DFFA2439

Q33905995-244FE451-41D7-4DBE-9788-A812894F1B54

Q33905995-405E8E67-96B2-429E-9D60-9D7447E35FAD

Q33905995-4C85E33B-FE45-4821-83D1-5C87945E8CE4

Q33905995-5FA41138-BBC9-4378-B425-128616E48575

Q33905995-8D0FFB1B-D671-4883-ADD8-4A1D9618AA35

Q33905995-BBB08B4D-A318-4631-B507-DB7F56CEB084

Q33905995-CE27AA8E-2B30-48DC-A8D8-7EE28A5F3474

Q33905995-D6B4ACB9-7106-4FB0-BE86-B16AB43A5A1B

P2860

Q33905995-02CCEAB5-CE09-4F04-B19E-A60C28D6BABC

Q33905995-151C93B3-27D8-4A5F-A510-B8E73ACABD53

Q33905995-17D6784E-4136-4598-91EF-89F477BF1CF9

Q33905995-18BE5B4D-BDD4-4E4D-ABFA-AA6F6CED3CE6

Q33905995-1EF53902-82BF-4E93-8523-D39707F017F3

Q33905995-1FEF57E5-2217-4F63-9210-5BD6DCF700BE

Q33905995-21E79C92-3BF6-4559-A499-ED149A280621

Q33905995-2644CCBD-6C15-4ECB-A027-790687DA59A0

Q33905995-2B779760-E5D7-4C1F-90C5-ED8BA9C01F1D

Q33905995-37E039B3-2C03-46C7-9523-6CEB03A47C32

P304

Q33905995-71DA36B0-A8EB-4518-BBD4-DBBB5F181187

P31

Q33905995-73AF1988-32B1-4EAD-89D0-2F220606FA34

P356

Q33905995-BCD5CF7E-B5FC-4C6C-96B2-D70B1036CFA8

P407

Q33905995-E47DA455-A653-4F7A-AB62-2095EA298035

P433

Q33905995-5748B6EE-2A84-43E9-A096-6A8C87E56AD6

P478

Q33905995-41A859F6-7951-4878-9D7F-BC0B008C4B4D

P577

Q33905995-0D5213F4-FCAC-4CC2-A2B4-C8E598BB950C

P5875

Q33905995-C966B689-90BA-45B4-8C29-31272BA1B956

P698

Q33905995-E1131D50-1BCF-4520-9D0A-6C226285ACC4

P921

Q33905995-BB3785AC-77F7-4E1A-B297-89E303BDE5F3

P932

Q33905995-9BC4DA00-F49F-4EA0-A9D4-C94553BA0919

P356

P1433

American Journal of Human Genetics

P1476

HLA-DRB1*1101: a significant risk factor for sarcoidosis in blacks and whites.

@en

P2093

ACCESS Group

http://www.w3.org/2001/XMLSchema#string

Benjamin A Rybicki

http://www.w3.org/2001/XMLSchema#string

Bojana Beznik-Cizman

http://www.w3.org/2001/XMLSchema#string

Bruce Thompson

http://www.w3.org/2001/XMLSchema#string

Dimitri Monos

http://www.w3.org/2001/XMLSchema#string

Eleni Magira

http://www.w3.org/2001/XMLSchema#string

Janardan P Pandey

http://www.w3.org/2001/XMLSchema#string

Lee S Newman

http://www.w3.org/2001/XMLSchema#string

Margaret Frederick

http://www.w3.org/2001/XMLSchema#string

Mary Maliarik

http://www.w3.org/2001/XMLSchema#string

P2860

Complete sequence and gene map of a human major histocompatibility complex. The MHC sequencing consortium

Decreased frequency of the HLA-DRB1*11 allele in patients with chronic hepatitis C virus infection

Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide

HLA-DPB1 glutamate 69: a genetic marker of beryllium disease

TNF-alpha, IL1-beta, and immunoglobulin (GM and KM) gene polymorphisms in sarcoidosis

Associations of HLA class II alleles with pulmonary tuberculosis in Thais

Note on the sampling error of the difference between correlated proportions or percentages

Defining organ involvement in sarcoidosis: the ACCESS proposed instrument. ACCESS Research Group. A Case Control Etiologic Study of Sarcoidosis.

HLA-DRB1*03, DRB1*11 or DRB1*12 and their respective DRB3 specificities in clinical variants of sarcoidosis.

The HLA system. First of two parts.

P304

720-735

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1086/378097

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

73

http://www.w3.org/2001/XMLSchema#string

P577

2003-08-20T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

9080688

http://www.w3.org/2001/XMLSchema#string

P698

14508706

http://www.w3.org/2001/XMLSchema#string

P921

P932

1180597

http://www.w3.org/2001/XMLSchema#string